Delivery Order SPE2DB22D3004-SPE2DB25FQ72D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,804.93 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,861.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Briviact 25 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded a $8,509.97 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Briviact 100 mg, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,002.64 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Briviact 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,044.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 100 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $11,044.73. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,789.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg, a psychiatric medication. This award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical distributor will perform the work at its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $5,572.14 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ72DDelivery Order
The Defense Logistics Agency awarded a $3,168.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with an ultimate completion date of September 15, 2025. The award, issued on September 12, 2025, carries no set-aside designation and represents a competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The current delivery order for Briviact, a psychiatric medication, exemplifies the company's role in supplying essential medications through the DLA's pharmaceutical supply chain to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/12/25 |